To identify the functional role of H2BC5, H2BC9, H2BC11 and H2BC21 in gliomas, the A172 and U-87 MG cell lines were treated with siRNA against the H2B genes (Figure 11A). This evidence concerns the gene H2BC5 and central nervous system cancer.